MarketsStocksSUVEN
SU

Suven Life Sciences Ltd

NSE: SUVENBSE: 530239Healthcare
266.70
-3.14%
NSE · 15-min delayed
Prev Close
₹234.28
Day High
₹279.00
Day Low
₹262.50
Mkt Cap
₹7,367 Cr
P / E
-
P / B
12.4
ROE
-46.7%
52W High
₹299.99
52W Low
₹124.11
Key Metrics
Market Cap
₹7,367 Cr
P / E
-
P / B
12.4
ROCE
-46.7%
ROE
-46.7%
Div Yield
-
Revenue · ₹ Cr
14
FY20
13
FY21
12
FY22
14
FY23
12
FY24
7
FY25
7
FY26
Net Profit · ₹ Cr
-94
FY20
-72
FY21
-122
FY22
-118
FY23
-105
FY24
-161
FY25
-276
FY26
EPS · ₹ per share
₹7.5
FY16
₹6.8
FY19
₹-2.0
FY20
₹-5.7
FY21
₹-9.6
FY22
₹-6.6
FY23
₹-4.8
FY24
P / E Ratio · price ÷ TTM EPS
73350627905000Jun 21Jan 23Oct 24Jun 26
P/E 761.0×Median 263.5×TTM EPS
Q1 2026 snapshot
Sales
₹8 Cr
Operating profit
-
OPM
-
Net profit
₹-46 Cr
EPS
₹-2.02
Scorecard · 7 axes
Quality
Weak
33/100
Valuation
-
Growth
Bad
-29.4%
Profitability
Bad
-46.7%
Performance
Avg
+16.7%
Entry Point
Avg
89%
Red Flags
Strong
0 flags
Shareholding Pattern
70.2%Promoter
Promoter70.2%
FII0.9%
DII4.6%
Public24.3%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue1.612.692.474.75.588.3
Net Profit-39.117-43.945-51.517-77.31-101.922-45.596
NPM %-2429.8%-1633.6%-2085.7%-1644.9%-1826.6%-549.3%
AlertPre-trade